Status:
COMPLETED
The Effects of Moviprep With Simethicone on Colonic Bubbles
Lead Sponsor:
Thomas Jefferson University
Conditions:
Bubbles in Colon at Time of Colonoscopy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the administration of PEG along with simethicone will reduce the incidence of colonic bubbles that interfere with polyp detection.
Detailed Description
evaluating if simethicone is better than placebo at decreasing gas in the colon at time of colonoscopy so that it is easier for the endoscopist to see polyps
Eligibility Criteria
Inclusion
- Elective outpatients undergoing colonoscopy using split dose PEG-ELS with sodium ascorbate and ascorbic acid
Exclusion
- Unable or unwilling to give informed consent
- Age \< 18 years
- Pregnant
- Breast feeding
- Established or suspected gastroparesis
- Pseudo-obstruction - established or suspected
- Severe constipation (\< 1 BM a week)
- Bowel obstruction
- Greater than 50% resection of colon
- Chronic nausea or vomiting
- Consumed \> 100% standard dose of PEG-ELS (i.e. more than 2L)
- G6PD deficiency
- PEG allergy
- Significant psychiatric illness
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01209806
Start Date
November 1 2009
End Date
September 1 2012
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107